 Neel Butala
Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcatheter Aortic Valve Replacement | 15 | 2025 | 121 | 8.120 |
Why?
| | Aortic Valve Stenosis | 11 | 2025 | 218 | 6.160 |
Why?
| | Percutaneous Coronary Intervention | 21 | 2025 | 467 | 5.070 |
Why?
| | Embolic Protection Devices | 4 | 2024 | 12 | 2.570 |
Why?
| | Administrative Claims, Healthcare | 4 | 2025 | 26 | 2.020 |
Why?
| | Heart Valve Prosthesis Implantation | 6 | 2025 | 177 | 1.860 |
Why?
| | Medicare | 16 | 2025 | 708 | 1.790 |
Why?
| | Coronary Artery Disease | 6 | 2023 | 679 | 1.770 |
Why?
| | Registries | 13 | 2025 | 1899 | 1.670 |
Why?
| | Aortic Valve | 7 | 2025 | 347 | 1.580 |
Why?
| | Treatment Outcome | 30 | 2025 | 10219 | 1.510 |
Why?
| | Myocardial Infarction | 9 | 2024 | 1021 | 1.510 |
Why?
| | Stroke | 8 | 2025 | 1071 | 1.310 |
Why?
| | Data Accuracy | 3 | 2024 | 58 | 1.230 |
Why?
| | Platelet Aggregation Inhibitors | 7 | 2023 | 443 | 1.170 |
Why?
| | ST Elevation Myocardial Infarction | 4 | 2021 | 52 | 1.170 |
Why?
| | Patient Readmission | 7 | 2020 | 653 | 1.150 |
Why?
| | Insurance Claim Review | 2 | 2025 | 64 | 1.150 |
Why?
| | Risk Factors | 22 | 2025 | 9786 | 1.140 |
Why?
| | Directories as Topic | 2 | 2024 | 6 | 1.060 |
Why?
| | Hospitals | 5 | 2023 | 637 | 1.060 |
Why?
| | Insurance Carriers | 2 | 2024 | 11 | 1.050 |
Why?
| | Hospital Mortality | 7 | 2024 | 848 | 1.030 |
Why?
| | United States | 30 | 2025 | 13871 | 1.010 |
Why?
| | Aged | 33 | 2025 | 22061 | 0.950 |
Why?
| | Physicians | 2 | 2024 | 866 | 0.940 |
Why?
| | Risk Assessment | 8 | 2025 | 3262 | 0.920 |
Why?
| | Endpoint Determination | 1 | 2025 | 76 | 0.900 |
Why?
| | Insurance, Health | 2 | 2024 | 267 | 0.890 |
Why?
| | Atherectomy, Coronary | 1 | 2023 | 10 | 0.860 |
Why?
| | Time Factors | 13 | 2025 | 6555 | 0.850 |
Why?
| | Aged, 80 and over | 16 | 2025 | 7052 | 0.850 |
Why?
| | Longevity | 1 | 2024 | 155 | 0.830 |
Why?
| | Heart Valve Prosthesis | 2 | 2021 | 112 | 0.820 |
Why?
| | Mortality | 3 | 2018 | 307 | 0.820 |
Why?
| | Shock, Cardiogenic | 1 | 2023 | 60 | 0.810 |
Why?
| | Postoperative Hemorrhage | 2 | 2021 | 87 | 0.790 |
Why?
| | Frailty | 2 | 2023 | 152 | 0.790 |
Why?
| | Surgical Procedures, Operative | 1 | 2025 | 244 | 0.780 |
Why?
| | Coronary Occlusion | 1 | 2022 | 18 | 0.780 |
Why?
| | Diabetes Mellitus | 3 | 2015 | 1001 | 0.770 |
Why?
| | Vascular Calcification | 1 | 2023 | 107 | 0.760 |
Why?
| | Humans | 59 | 2025 | 129625 | 0.750 |
Why?
| | Patient Discharge | 5 | 2024 | 836 | 0.740 |
Why?
| | Anticoagulants | 3 | 2021 | 637 | 0.710 |
Why?
| | Preventive Health Services | 2 | 2013 | 145 | 0.710 |
Why?
| | Mitral Valve | 2 | 2021 | 85 | 0.690 |
Why?
| | Clinical Trials as Topic | 4 | 2023 | 1005 | 0.670 |
Why?
| | Intensive Care Units | 2 | 2023 | 735 | 0.670 |
Why?
| | Anesthesia, General | 1 | 2020 | 54 | 0.670 |
Why?
| | Data Collection | 1 | 2023 | 650 | 0.660 |
Why?
| | Conscious Sedation | 1 | 2020 | 85 | 0.640 |
Why?
| | Endovascular Procedures | 1 | 2023 | 301 | 0.640 |
Why?
| | Data Mining | 1 | 2020 | 110 | 0.630 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 301 | 0.620 |
Why?
| | Students, Medical | 2 | 2013 | 322 | 0.590 |
Why?
| | Postoperative Complications | 3 | 2025 | 2477 | 0.580 |
Why?
| | Economics, Hospital | 1 | 2018 | 21 | 0.580 |
Why?
| | Kidney Transplantation | 2 | 2015 | 670 | 0.580 |
Why?
| | Betacoronavirus | 1 | 2020 | 250 | 0.570 |
Why?
| | Peripheral Arterial Disease | 2 | 2023 | 458 | 0.570 |
Why?
| | Stents | 2 | 2021 | 504 | 0.560 |
Why?
| | Practice Patterns, Physicians' | 3 | 2021 | 1271 | 0.550 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2018 | 94 | 0.550 |
Why?
| | Occupational Exposure | 1 | 2020 | 299 | 0.540 |
Why?
| | Quality of Health Care | 3 | 2016 | 604 | 0.540 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2739 | 0.510 |
Why?
| | Coronary Angiography | 3 | 2023 | 306 | 0.500 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 340 | 0.500 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.490 |
Why?
| | Male | 31 | 2025 | 63670 | 0.490 |
Why?
| | Databases, Factual | 5 | 2025 | 1269 | 0.490 |
Why?
| | Academic Medical Centers | 2 | 2015 | 475 | 0.470 |
Why?
| | Pneumonia | 2 | 2018 | 617 | 0.470 |
Why?
| | Seasons | 1 | 2017 | 494 | 0.470 |
Why?
| | Angina Pectoris | 3 | 2022 | 67 | 0.460 |
Why?
| | Female | 30 | 2025 | 68734 | 0.450 |
Why?
| | Health Personnel | 1 | 2020 | 653 | 0.450 |
Why?
| | Healthcare Disparities | 1 | 2020 | 578 | 0.440 |
Why?
| | Waiting Lists | 1 | 2015 | 237 | 0.430 |
Why?
| | Retrospective Studies | 10 | 2025 | 14522 | 0.430 |
Why?
| | Incidence | 6 | 2021 | 2641 | 0.420 |
Why?
| | Delayed Graft Function | 1 | 2013 | 30 | 0.410 |
Why?
| | Graft Survival | 1 | 2015 | 513 | 0.410 |
Why?
| | Intracranial Embolism | 2 | 2024 | 31 | 0.400 |
Why?
| | Tissue Donors | 1 | 2015 | 391 | 0.400 |
Why?
| | Income | 2 | 2022 | 188 | 0.390 |
Why?
| | Middle Aged | 17 | 2025 | 31136 | 0.380 |
Why?
| | Tissue and Organ Procurement | 1 | 2015 | 289 | 0.380 |
Why?
| | Community Health Centers | 1 | 2012 | 57 | 0.370 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 226 | 0.370 |
Why?
| | Hospitalization | 4 | 2020 | 2057 | 0.360 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 1947 | 0.350 |
Why?
| | Ambulatory Care | 1 | 2015 | 506 | 0.350 |
Why?
| | Disease Management | 1 | 2015 | 588 | 0.350 |
Why?
| | Urban Renewal | 1 | 2010 | 4 | 0.350 |
Why?
| | Odds Ratio | 5 | 2021 | 1019 | 0.340 |
Why?
| | Poverty Areas | 1 | 2010 | 35 | 0.340 |
Why?
| | Urban Health | 1 | 2010 | 79 | 0.340 |
Why?
| | Sanitation | 1 | 2010 | 52 | 0.330 |
Why?
| | Ischemic Attack, Transient | 2 | 2021 | 60 | 0.330 |
Why?
| | Water Supply | 1 | 2010 | 74 | 0.330 |
Why?
| | Communicable Disease Control | 1 | 2010 | 75 | 0.330 |
Why?
| | Quality Improvement | 2 | 2018 | 1101 | 0.320 |
Why?
| | Efficiency, Organizational | 1 | 2010 | 133 | 0.320 |
Why?
| | Heart Failure | 2 | 2018 | 2133 | 0.280 |
Why?
| | Mass Screening | 2 | 2013 | 1190 | 0.280 |
Why?
| | Sex Characteristics | 2 | 2014 | 736 | 0.280 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3080 | 0.270 |
Why?
| | Chronic Disease | 2 | 2023 | 1720 | 0.270 |
Why?
| | Life Expectancy | 2 | 2016 | 60 | 0.250 |
Why?
| | Blood Glucose | 1 | 2015 | 2100 | 0.230 |
Why?
| | Propensity Score | 3 | 2021 | 264 | 0.230 |
Why?
| | Fee-for-Service Plans | 1 | 2025 | 87 | 0.230 |
Why?
| | Delivery of Health Care | 2 | 2018 | 898 | 0.230 |
Why?
| | Medicare Part C | 1 | 2025 | 28 | 0.230 |
Why?
| | Drug Therapy, Combination | 3 | 2023 | 1042 | 0.220 |
Why?
| | Protective Factors | 1 | 2024 | 91 | 0.220 |
Why?
| | Limb Salvage | 1 | 2023 | 57 | 0.210 |
Why?
| | Purinergic P2Y Receptor Antagonists | 2 | 2023 | 66 | 0.210 |
Why?
| | Connecticut | 2 | 2014 | 26 | 0.210 |
Why?
| | Specialization | 1 | 2024 | 145 | 0.210 |
Why?
| | Cross-Sectional Studies | 5 | 2022 | 5075 | 0.210 |
Why?
| | Primary Health Care | 1 | 2013 | 1686 | 0.210 |
Why?
| | Chest Pain | 2 | 2020 | 88 | 0.200 |
Why?
| | Medicine | 1 | 2024 | 119 | 0.200 |
Why?
| | Disability Evaluation | 1 | 2024 | 285 | 0.200 |
Why?
| | Nitroglycerin | 1 | 2022 | 17 | 0.200 |
Why?
| | Follow-Up Studies | 4 | 2021 | 4894 | 0.190 |
Why?
| | Coronary Stenosis | 1 | 2021 | 39 | 0.180 |
Why?
| | Glycyrrhiza | 1 | 2020 | 3 | 0.180 |
Why?
| | Glycyrrhetinic Acid | 1 | 2020 | 7 | 0.180 |
Why?
| | Mineralocorticoids | 1 | 2020 | 8 | 0.180 |
Why?
| | Hyperaldosteronism | 1 | 2020 | 8 | 0.170 |
Why?
| | Mitral Valve Insufficiency | 1 | 2021 | 67 | 0.170 |
Why?
| | Ischemia | 1 | 2023 | 406 | 0.170 |
Why?
| | Receptors, Purinergic P2Y12 | 1 | 2020 | 6 | 0.170 |
Why?
| | Bioprosthesis | 1 | 2020 | 40 | 0.170 |
Why?
| | Cardiology Service, Hospital | 1 | 2020 | 23 | 0.170 |
Why?
| | Cardiologists | 1 | 2020 | 46 | 0.160 |
Why?
| | International Classification of Diseases | 1 | 2020 | 122 | 0.160 |
Why?
| | Thrombosis | 2 | 2020 | 348 | 0.160 |
Why?
| | Drug Utilization | 1 | 2020 | 171 | 0.160 |
Why?
| | Death, Sudden, Cardiac | 1 | 2020 | 179 | 0.160 |
Why?
| | Adult | 7 | 2023 | 35599 | 0.150 |
Why?
| | Risk | 1 | 2020 | 855 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2020 | 264 | 0.140 |
Why?
| | Health Services Research | 1 | 2020 | 391 | 0.140 |
Why?
| | Calcium | 1 | 2023 | 1212 | 0.140 |
Why?
| | New York | 1 | 2017 | 128 | 0.140 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 298 | 0.140 |
Why?
| | Outpatients | 1 | 2020 | 373 | 0.130 |
Why?
| | Decision Support Techniques | 1 | 2020 | 398 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1501 | 0.130 |
Why?
| | Elective Surgical Procedures | 1 | 2017 | 164 | 0.130 |
Why?
| | Brain Ischemia | 1 | 2019 | 321 | 0.130 |
Why?
| | California | 1 | 2017 | 400 | 0.130 |
Why?
| | Young Adult | 5 | 2022 | 12455 | 0.130 |
Why?
| | Medicaid | 1 | 2020 | 431 | 0.120 |
Why?
| | Glycemic Index | 1 | 2015 | 25 | 0.120 |
Why?
| | Disease Progression | 1 | 2022 | 2627 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1365 | 0.110 |
Why?
| | Cold Ischemia | 1 | 2013 | 30 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 3774 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2016 | 287 | 0.100 |
Why?
| | Physical Examination | 1 | 2013 | 234 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1491 | 0.100 |
Why?
| | Hemorrhage | 3 | 2023 | 680 | 0.100 |
Why?
| | Atrial Fibrillation | 1 | 2016 | 376 | 0.100 |
Why?
| | Egypt | 1 | 2011 | 10 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2016 | 527 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2012 | 127 | 0.090 |
Why?
| | Linear Models | 1 | 2013 | 819 | 0.090 |
Why?
| | India | 1 | 2010 | 171 | 0.080 |
Why?
| | Policy Making | 1 | 2010 | 88 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2006 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1499 | 0.080 |
Why?
| | Communicable Diseases | 1 | 2010 | 152 | 0.070 |
Why?
| | Regression Analysis | 1 | 2010 | 997 | 0.070 |
Why?
| | Cardiac Catheterization | 2 | 2021 | 520 | 0.070 |
Why?
| | Health Policy | 1 | 2010 | 353 | 0.070 |
Why?
| | Aspirin | 2 | 2023 | 380 | 0.070 |
Why?
| | Comorbidity | 2 | 2025 | 1547 | 0.070 |
Why?
| | Logistic Models | 2 | 2021 | 1986 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2442 | 0.050 |
Why?
| | Length of Stay | 2 | 2018 | 1122 | 0.050 |
Why?
| | Coronary Artery Bypass | 1 | 2023 | 224 | 0.050 |
Why?
| | Drug-Eluting Stents | 1 | 2021 | 74 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2017 | 3628 | 0.040 |
Why?
| | Hypokalemia | 1 | 2020 | 24 | 0.040 |
Why?
| | Aldosterone | 1 | 2020 | 43 | 0.040 |
Why?
| | Ventricular Fibrillation | 1 | 2020 | 57 | 0.040 |
Why?
| | Prasugrel Hydrochloride | 1 | 2020 | 22 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2022 | 260 | 0.040 |
Why?
| | Blood Chemical Analysis | 1 | 2020 | 97 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2020 | 300 | 0.040 |
Why?
| | Skilled Nursing Facilities | 1 | 2021 | 130 | 0.040 |
Why?
| | Cause of Death | 1 | 2021 | 395 | 0.040 |
Why?
| | Hydrocortisone | 1 | 2020 | 306 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2020 | 557 | 0.040 |
Why?
| | Electroencephalography | 1 | 2020 | 409 | 0.040 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2020 | 233 | 0.040 |
Why?
| | Algorithms | 1 | 2025 | 1616 | 0.030 |
Why?
| | Child, Preschool | 2 | 2023 | 10490 | 0.030 |
Why?
| | Dabigatran | 1 | 2016 | 21 | 0.030 |
Why?
| | Postoperative Period | 1 | 2017 | 330 | 0.030 |
Why?
| | Administration, Oral | 1 | 2018 | 787 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1432 | 0.030 |
Why?
| | Warfarin | 1 | 2016 | 147 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 2016 | 137 | 0.030 |
Why?
| | Pyridones | 1 | 2016 | 158 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2016 | 179 | 0.030 |
Why?
| | Rivaroxaban | 1 | 2016 | 252 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 851 | 0.030 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 321 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1198 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1269 | 0.030 |
Why?
| | Pyrazoles | 1 | 2016 | 404 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3152 | 0.020 |
Why?
| | Adolescent | 2 | 2022 | 20412 | 0.020 |
Why?
| | Child | 2 | 2022 | 20884 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2512 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5756 | 0.020 |
Why?
| | Infant | 1 | 2020 | 8995 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 5415 | 0.010 |
Why?
|
|
Butala's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|